glp 1 and gip hormones The dual glucose-dependent insulinotropic polypeptide (GIP) glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology Understanding GLP-1 vs. GIP Medications:
Description
21 Tennessee Medicaid approved coverage effective January 1, 2026
Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP
Headaches during GLP-1 therapy represent one of several potential side effects that warrant careful monitoring and provider communication
Current views on type 2 diabetes
